Ian B. L. Walker, Senior Director Global Community Impact, Johnson & Johnson
Ian Walker is a Senior Director within the Johnson & Johnson Global Community Impact team and guides the company's strategy and execution in the area of Social Business Practice, mainly in EMEA and Asia Pacific. The Global Community Impacts team is tasked with “Supporting and championing the people on the front lines, who are at the heart of delivering care”.
Prior to joining the Global Community Impact team in September 2014, Ian was Managing Director of the Johnson & Johnson MISSA (Maghreb, Iran and Sub Saharan Africa) business for Johnson & Johnson’s Medical Device business for seven years. During this period, the business enjoyed significant growth, culminating in the award of the 2014 Queen’s Award for Enterprise in International Trade. Ian has also held positions as UK Marketing Director for Ethicon, EMEA Marketing Director for CardioVascular and Marketing Director based at Ethicon’s World wide head office in Somerville, New Jersey, USA.
Ian is also member of the UK’s Johnson & Johnson Medical Ltd Statutory Board of Directors.
Ian has a great passion for Africa and has a particular interest in the area of Obstetric Fistula prevention and repair, and Surgical capacity building.
Ian has a BSc (Hons) from the University of Aberdeen, MBA from University of Edinburgh and is a Fellow of the Chartered Institute of Marketing. Ian is married and lives in Fife with a wife, two boys, a Pyrenean Mountain Dog, two kittens, and six chickens.
1st Panel Breakout: Underserved/Minority Populations
- Dr. Cedric Bright, Associate Dean of Inclusive Excellence, UNC School of Medicine
- Dr. Terri Phoenix, Director, LGBTQ Center at UNC Chapel Hill
- Brian Toomey, CEO, Piedmont Health Services
- Dr. Troy Trygstad, Vice President of Pharmacy Programs, Community Care of North Carolina
1st Panel Breakout: Global Health
- Dr. Dawn Chin-Quee, Scientist of Program Sciences, FHI360
- Maureen Corbett, Vice President of Programs, IntraHealth International, Inc.
- Peter Hare, Professor and Consultant, UNC Kenan-Flagler
- Markus Saba, Senior Director Global Commercialization, Lilly Diabetes at Eli Lilly and Company
2nd Panel Breakout: Provider Shortage
- Dr. Sam Cykert, Director, UNC Program for Health and Clinical Informatics
- Dr. Carlton D. Miller, Lead Physician, Novant Health Durham Internal Medicine
- Franklin Niblock, Rural NC Community Health Intervention Specialist, MedServe
- Dr. Sy Atezaz Saeed, Director, North Carolina Statewide Telepsychiatry Program (NC-STeP)
2nd Panel Breakout: Insurance
- Elizabeth Davies, Director, GlaxoSmithKline
- Jen Joy, Senior Director of Core Product Solutions, Cigna
- Jennifer Simmons, Project Manager of NC Navigator Consortium, Legal Aid of North Carolina
- Speaker To Be Determined, Triangle Insights Group, LLC
3rd Panel Breakout: Opioid Epidemic
- Kevin Bingham, Principal, Deloitte Consulting
- Brendon Collins, Tanezumab Associate Brand Manager, Eli Lilly
- Dr. Susan Kansagra, North Carolina Department of Health & Human Services
- Louise Vincent, North Carolina Harm Reduction Coalition
3rd Panel Breakout: Digital Health
- Peter Johnson, Co-founder and Principal, MedSurgPI
- Steve Laster, Senior Manager of Digital Strategy, MicroMass Communications
- Christian Nimsch, Head of Healthcare and Life Sciences Technical & Industry Consulting, SAS
- John Rosano, Global Corporate Strategy & Business Development, Cigna
- Ed Trautman, Vice President of Bioinformatics, LabCorp
Capstone Panel: Public Policy
- Jonathan Oberlander, PhD, Professor and Chair, Department of Social Medicine, University of North Carolina School of Medicine
- Congressman David Price, U.S. Congressman, 4th District of North Carolina
- Melissa Speck, Director of Health Policy Office, BCBS of North Carolina